Cumberland Pharmaceuticals (CPIX) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Q3 2025 value amounting to $0.2.
- Cumberland Pharmaceuticals' Debt to Equity fell 6910.36% to $0.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.2, marking a year-over-year decrease of 6910.36%. This contributed to the annual value of $0.67 for FY2024, which is 5478.63% up from last year.
- As of Q3 2025, Cumberland Pharmaceuticals' Debt to Equity stood at $0.2, which was down 6910.36% from $0.19 recorded in Q2 2025.
- Cumberland Pharmaceuticals' 5-year Debt to Equity high stood at $0.67 for Q4 2024, and its period low was $0.18 during Q1 2025.
- Moreover, its 5-year median value for Debt to Equity was $0.43 (2023), whereas its average is $0.41.
- Its Debt to Equity has fluctuated over the past 5 years, first skyrocketed by 8086.17% in 2024, then plummeted by 6934.11% in 2025.
- Cumberland Pharmaceuticals' Debt to Equity (Quarter) stood at $0.35 in 2021, then grew by 27.5% to $0.45 in 2022, then fell by 3.32% to $0.43 in 2023, then skyrocketed by 54.79% to $0.67 in 2024, then tumbled by 69.98% to $0.2 in 2025.
- Its last three reported values are $0.2 in Q3 2025, $0.19 for Q2 2025, and $0.18 during Q1 2025.